位置:首页 > 蛋白库 > PPT2_HUMAN
PPT2_HUMAN
ID   PPT2_HUMAN              Reviewed;         302 AA.
AC   Q9UMR5; A2ABC9; A2ABD1; A2ARM7; A2BFH7; A2BFH9; A2BFI2; A8K9L4; B0S868;
AC   G8JLE1; O14799; Q0P6K0; Q5JP13; Q5JP14; Q5JQF0; Q5SSX4; Q5SSX5; Q5SSX6;
AC   Q5STJ4; Q5STJ5; Q5STJ6; Q6FI80; Q99945;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   03-AUG-2022, entry version 177.
DE   RecName: Full=Lysosomal thioesterase PPT2;
DE            Short=PPT-2;
DE            EC=3.1.2.-;
DE   AltName: Full=S-thioesterase G14;
DE   Flags: Precursor;
GN   Name=PPT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, GLYCOSYLATION, PH DEPENDENCE, AND
RP   VARIANT TRP-5.
RX   PubMed=9341199; DOI=10.1074/jbc.272.43.27456;
RA   Soyombo A.A., Hofmann S.L.;
RT   "Molecular cloning and expression of palmitoyl-protein thioesterase 2
RT   (PPT2), a homolog of lysosomal palmitoyl-protein thioesterase with a
RT   distinct substrate specificity.";
RL   J. Biol. Chem. 272:27456-27463(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), GLYCOSYLATION, FUNCTION, AND
RP   VARIANT TRP-5.
RX   PubMed=10417332; DOI=10.1042/bj3410679;
RA   Aguado B., Campbell R.D.;
RT   "Characterization of a human MHC class III region gene product with S-
RT   thioesterase activity.";
RL   Biochem. J. 341:679-689(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT TRP-5.
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-5.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT TRP-5.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS TRP-5 AND
RP   GLU-34.
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D.,
RA   Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS TRP-5 AND
RP   GLU-34.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT TRP-5.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-5.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS), FUNCTION, KINETIC PARAMETERS,
RP   MUTAGENESIS OF SER-111; ASP-228; HIS-283 AND HIS-287, GLYCOSYLATION AT
RP   ASN-190, AND DISULFIDE BONDS.
RX   PubMed=12855696; DOI=10.1074/jbc.m301225200;
RA   Calero G., Gupta P., Nonato M.C., Tandel S., Biehl E.R., Hofmann S.L.,
RA   Clardy J.;
RT   "The crystal structure of palmitoyl protein thioesterase-2 (PPT2) reveals
RT   the basis for divergent substrate specificities of the two lysosomal
RT   thioesterases, PPT1 and PPT2.";
RL   J. Biol. Chem. 278:37957-37964(2003).
RN   [14]
RP   VARIANTS TRP-5 AND GLU-34.
RX   PubMed=10051407; DOI=10.1006/geno.1998.5703;
RA   Soyombo A.A., Yi W., Hofmann S.L.;
RT   "Structure of the human palmitoyl-protein thioesterase-2 gene (PPT2) in the
RT   major histocompatibility complex on chromosome 6p21.3.";
RL   Genomics 56:208-216(1999).
CC   -!- FUNCTION: Removes thioester-linked fatty acyl groups from various
CC       substrates including S-palmitoyl-CoA. Has the highest S-thioesterase
CC       activity for the acyl groups palmitic and myristic acid followed by
CC       other short- and long-chain acyl substrates. However, because of
CC       structural constraints, is unable to remove palmitate from peptides or
CC       proteins. {ECO:0000269|PubMed:10417332, ECO:0000269|PubMed:12855696,
CC       ECO:0000269|PubMed:9341199}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=67 uM for S-palmitoyl-CoA {ECO:0000269|PubMed:12855696};
CC         KM=37 uM for S-palmitoyl-N-acetylcysteamine
CC         {ECO:0000269|PubMed:12855696};
CC         KM=117 uM for 4-methylumbelliferyl-6-S-palmitoyl-beta-D-
CC         glucopyranoside {ECO:0000269|PubMed:12855696};
CC         Vmax=1.7 umol/min/mg enzyme toward S-palmitoyl-CoA
CC         {ECO:0000269|PubMed:12855696};
CC         Vmax=3.3 umol/min/mg enzyme toward S-palmitoyl-N-acetylcysteamine
CC         {ECO:0000269|PubMed:12855696};
CC         Vmax=0.43 umol/min/mg enzyme toward 4-methylumbelliferyl-6-S-
CC         palmitoyl-beta-D-glucopyranoside {ECO:0000269|PubMed:12855696};
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:9341199};
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:9341199}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UMR5-1; Sequence=Displayed;
CC       Name=2; Synonyms=I;
CC         IsoId=Q9UMR5-2; Sequence=VSP_005188;
CC       Name=3;
CC         IsoId=Q9UMR5-3; Sequence=VSP_054027;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in skeletal
CC       muscle. {ECO:0000269|PubMed:9341199}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Catalytically inactive due to lack of His-
CC       283. May be produced at very low levels due to a premature stop codon
CC       in the mRNA, leading to nonsense-mediated mRNA decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the palmitoyl-protein thioesterase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally referred as a palmitoyl-protein thioesterase
CC       (palmitoyl-protein hydrolase). {ECO:0000305|PubMed:9341199}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAG38577.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF020543; AAB80730.1; -; mRNA.
DR   EMBL; AF020544; AAB80731.1; -; mRNA.
DR   EMBL; Y17958; CAB46981.1; -; mRNA.
DR   EMBL; AL110128; CAB53659.1; -; mRNA.
DR   EMBL; CR533546; CAG38577.1; ALT_INIT; mRNA.
DR   EMBL; AK292729; BAF85418.1; -; mRNA.
DR   EMBL; U89336; AAB47495.1; -; Genomic_DNA.
DR   EMBL; AL662828; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL845464; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX284686; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR753803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR812478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR933878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03597.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03591.1; -; Genomic_DNA.
DR   EMBL; BC001355; AAH01355.1; -; mRNA.
DR   CCDS; CCDS4740.1; -. [Q9UMR5-3]
DR   CCDS; CCDS4742.1; -. [Q9UMR5-1]
DR   RefSeq; NP_001191032.1; NM_001204103.1. [Q9UMR5-1]
DR   RefSeq; NP_005146.4; NM_005155.6. [Q9UMR5-1]
DR   RefSeq; NP_619731.2; NM_138717.2. [Q9UMR5-3]
DR   PDB; 1PJA; X-ray; 2.70 A; A=1-302.
DR   PDBsum; 1PJA; -.
DR   AlphaFoldDB; Q9UMR5; -.
DR   SMR; Q9UMR5; -.
DR   BioGRID; 114775; 50.
DR   IntAct; Q9UMR5; 9.
DR   STRING; 9606.ENSP00000354608; -.
DR   ChEMBL; CHEMBL2189137; -.
DR   ESTHER; human-PPT2; Palmitoyl-protein_thioesterase.
DR   GlyGen; Q9UMR5; 5 sites.
DR   iPTMnet; Q9UMR5; -.
DR   PhosphoSitePlus; Q9UMR5; -.
DR   BioMuta; PPT2; -.
DR   DMDM; 296453016; -.
DR   EPD; Q9UMR5; -.
DR   jPOST; Q9UMR5; -.
DR   MassIVE; Q9UMR5; -.
DR   MaxQB; Q9UMR5; -.
DR   PaxDb; Q9UMR5; -.
DR   PeptideAtlas; Q9UMR5; -.
DR   PRIDE; Q9UMR5; -.
DR   ProteomicsDB; 34200; -.
DR   ProteomicsDB; 85198; -. [Q9UMR5-1]
DR   ProteomicsDB; 85199; -. [Q9UMR5-2]
DR   Antibodypedia; 45479; 127 antibodies from 20 providers.
DR   DNASU; 9374; -.
DR   Ensembl; ENST00000324816.11; ENSP00000320528.6; ENSG00000221988.13. [Q9UMR5-1]
DR   Ensembl; ENST00000361568.6; ENSP00000354608.2; ENSG00000221988.13. [Q9UMR5-3]
DR   Ensembl; ENST00000375137.6; ENSP00000364279.2; ENSG00000221988.13. [Q9UMR5-1]
DR   Ensembl; ENST00000375143.6; ENSP00000364285.2; ENSG00000221988.13. [Q9UMR5-1]
DR   Ensembl; ENST00000383301.6; ENSP00000372789.2; ENSG00000206329.15.
DR   Ensembl; ENST00000395523.5; ENSP00000378894.1; ENSG00000221988.13. [Q9UMR5-1]
DR   Ensembl; ENST00000412651.6; ENSP00000416505.2; ENSG00000236649.10.
DR   Ensembl; ENST00000414356.6; ENSP00000398462.2; ENSG00000168452.21.
DR   Ensembl; ENST00000415972.1; ENSP00000408333.1; ENSG00000228116.9.
DR   Ensembl; ENST00000423347.6; ENSP00000406219.2; ENSG00000231618.10.
DR   Ensembl; ENST00000433748.5; ENSP00000410001.1; ENSG00000206256.14.
DR   Ensembl; ENST00000476214.5; ENSP00000432308.1; ENSG00000168452.21.
DR   Ensembl; ENST00000480383.5; ENSP00000432502.1; ENSG00000236649.10.
DR   Ensembl; ENST00000483565.5; ENSP00000431928.1; ENSG00000231618.10.
DR   Ensembl; ENST00000488579.5; ENSP00000434992.1; ENSG00000236649.10.
DR   Ensembl; ENST00000490624.5; ENSP00000433323.1; ENSG00000168452.21.
DR   Ensembl; ENST00000493809.5; ENSP00000436963.1; ENSG00000227600.11.
DR   Ensembl; ENST00000496937.5; ENSP00000432964.1; ENSG00000231618.10.
DR   Ensembl; ENST00000527704.5; ENSP00000433061.1; ENSG00000227600.11.
DR   GeneID; 9374; -.
DR   KEGG; hsa:9374; -.
DR   MANE-Select; ENST00000324816.11; ENSP00000320528.6; NM_005155.7; NP_005146.4.
DR   UCSC; uc003nzw.4; human. [Q9UMR5-1]
DR   CTD; 9374; -.
DR   DisGeNET; 9374; -.
DR   GeneCards; PPT2; -.
DR   HGNC; HGNC:9326; PPT2.
DR   HPA; ENSG00000221988; Low tissue specificity.
DR   MIM; 603298; gene.
DR   neXtProt; NX_Q9UMR5; -.
DR   OpenTargets; ENSG00000221988; -.
DR   OpenTargets; ENSG00000258388; -.
DR   PharmGKB; PA33689; -.
DR   VEuPathDB; HostDB:ENSG00000221988; -.
DR   eggNOG; KOG2541; Eukaryota.
DR   GeneTree; ENSGT00940000155779; -.
DR   HOGENOM; CLU_050129_1_0_1; -.
DR   InParanoid; Q9UMR5; -.
DR   OMA; AWHTRRD; -.
DR   OrthoDB; 836806at2759; -.
DR   PhylomeDB; Q9UMR5; -.
DR   TreeFam; TF323926; -.
DR   PathwayCommons; Q9UMR5; -.
DR   Reactome; R-HSA-75105; Fatty acyl-CoA biosynthesis.
DR   SignaLink; Q9UMR5; -.
DR   BioGRID-ORCS; 9374; 21 hits in 1080 CRISPR screens.
DR   EvolutionaryTrace; Q9UMR5; -.
DR   GeneWiki; PPT2; -.
DR   GenomeRNAi; 9374; -.
DR   Pharos; Q9UMR5; Tbio.
DR   PRO; PR:Q9UMR5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9UMR5; protein.
DR   Bgee; ENSG00000221988; Expressed in left ovary and 94 other tissues.
DR   ExpressionAtlas; Q9UMR5; baseline and differential.
DR   Genevisible; Q9UMR5; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0098599; F:palmitoyl hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0008474; F:palmitoyl-(protein) hydrolase activity; IEA:InterPro.
DR   GO; GO:0016790; F:thiolester hydrolase activity; IBA:GO_Central.
DR   GO; GO:0046949; P:fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002472; Palm_thioest.
DR   InterPro; IPR030295; PPT2.
DR   PANTHER; PTHR11247:SF27; PTHR11247:SF27; 1.
DR   PRINTS; PR00414; PPTHIESTRASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Lysosome; Reference proteome; Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..302
FT                   /note="Lysosomal thioesterase PPT2"
FT                   /id="PRO_0000025554"
FT   ACT_SITE        111
FT                   /note="Nucleophile"
FT   ACT_SITE        228
FT   ACT_SITE        283
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        190
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   CARBOHYD        206
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        109..117
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   DISULFID        165..176
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   DISULFID        276..296
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   VAR_SEQ         1
FT                   /note="M -> MKSCGSM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_054027"
FT   VAR_SEQ         256..300
FT                   /note="VYLRDSFGLKTLLARGAIVRCPMAGISHTAWHSNRTLYETCIEPW -> PAR
FT                   PTHQSELLLLRLVCLKPPRRKKPACRVQRQSESWGPGLSCA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9341199"
FT                   /id="VSP_005188"
FT   VARIANT         5
FT                   /note="C -> W (in dbSNP:rs3134604)"
FT                   /evidence="ECO:0000269|PubMed:10051407,
FT                   ECO:0000269|PubMed:10417332, ECO:0000269|PubMed:11230166,
FT                   ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:14656967,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9341199, ECO:0000269|Ref.4,
FT                   ECO:0000269|Ref.8"
FT                   /id="VAR_027107"
FT   VARIANT         34
FT                   /note="A -> E (in dbSNP:rs3096696)"
FT                   /evidence="ECO:0000269|PubMed:10051407,
FT                   ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:14656967"
FT                   /id="VAR_027108"
FT   MUTAGEN         111
FT                   /note="S->A: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   MUTAGEN         228
FT                   /note="D->A: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   MUTAGEN         283
FT                   /note="H->A: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   MUTAGEN         287
FT                   /note="H->A: No effect on enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   CONFLICT        189
FT                   /note="L -> P (in Ref. 4; CAG38577)"
FT                   /evidence="ECO:0000305"
FT   STRAND          39..42
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           49..52
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           53..62
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           77..80
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           83..100
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   STRAND          105..110
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           112..123
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   STRAND          129..136
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           147..152
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           158..165
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           170..172
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           175..178
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           185..191
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           195..198
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           207..214
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   STRAND          218..224
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   STRAND          229..233
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           234..238
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           251..253
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           255..258
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   TURN            259..262
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           264..269
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   STRAND          273..277
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   TURN            283..287
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           290..296
FT                   /evidence="ECO:0007829|PDB:1PJA"
FT   HELIX           298..300
FT                   /evidence="ECO:0007829|PDB:1PJA"
SQ   SEQUENCE   302 AA;  34225 MW;  E242D677970B4BEA CRC64;
     MLGLCGQRLP AAWVLLLLPF LPLLLLAAPA PHRASYKPVI VVHGLFDSSY SFRHLLEYIN
     ETHPGTVVTV LDLFDGRESL RPLWEQVQGF REAVVPIMAK APQGVHLICY SQGGLVCRAL
     LSVMDDHNVD SFISLSSPQM GQYGDTDYLK WLFPTSMRSN LYRICYSPWG QEFSICNYWH
     DPHHDDLYLN ASSFLALING ERDHPNATVW RKNFLRVGHL VLIGGPDDGV ITPWQSSFFG
     FYDANETVLE MEEQLVYLRD SFGLKTLLAR GAIVRCPMAG ISHTAWHSNR TLYETCIEPW
     LS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024